Breaking News Instant updates and real-time market news.

ATI

Allegheny Technologies

$25.91

-0.325 (-1.24%)

, RYCEY

Rolls-Royce

$0.00

(0.00%)

07:34
04/04/19
04/04
07:34
04/04/19
07:34

Allegheny Technologies extends long-term purchase agreement with Rolls-Royce

Allegheny Technologies Incorporated (ATI) announced that it has extended its Long-Term Purchase Agreement with Rolls-Royce (RYCEY) to supply rotating disc quality specialty materials for their Trent engine family. The LTPA extends Rolls-Royce and ATI's agreement through 2029.

ATI

Allegheny Technologies

$25.91

-0.325 (-1.24%)

RYCEY

Rolls-Royce

$0.00

(0.00%)

  • 08

    Apr

  • 09

    Apr

  • 10

    Apr

  • 23

    Apr

ATI Allegheny Technologies
$25.91

-0.325 (-1.24%)

11/06/18
11/06/18
UPGRADE
Target $34

Buy
Allegheny Technologies upgraded to Buy following channel checks at Longbow
As previously reported, Longbow analyst Chris Olin upgraded Allegheny Technologies to Buy from Neutral. His checks with several contacts in the specialty materials channel gives Olin renewed confidence that jet engine makers and OEMs are on track to reach their aggressive 2018 production targets and will likely issue "aggressive" delivery guidance for 2019, the analyst told investors in his note issued prior to the market open. He set a $34 price target on Allegheny Technologies shares.
12/06/18
BREN
12/06/18
INITIATION
Target $35
BREN
Buy
Allegheny Technologies initiated with a Buy at Berenberg
Berenberg started Allegheny Technologies with a Buy rating and $35 price target.
02/14/19
MACQ
02/14/19
INITIATION
Target $34
MACQ
Outperform
Allegheny Technologies initiated with an Outperform at Macquarie
Macquarie analyst Xiao Feng started Allegheny Technologies with an Outperform rating and $34 price target. The company is "riding the wave" of aerospace growth while strategic actions in its Flat Rolled Products segment provides additional earnings power, Xiao tells investors in a research note. The analyst believes Allegheny's targets of high-single-digit revenue growth, 150 basis points operating margin improvements in 2019 and $3B in revenue at 20% margins in 2021 are achievable.
02/14/19
02/14/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Catasys (CATS) initiated with an Outperform at Oppenheimer. 2. Harmonic (HLIT) initiated with a Buy at Needham. 3. Allegheny Technologies (ATI) initiated with an Outperform at Macquarie. 4. ABM (ABM) initiated with a Buy at Maxim. 5. CSG (CSGS) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
RYCEY Rolls-Royce
$0.00

(0.00%)

06/18/18
FBCO
06/18/18
UPGRADE
FBCO
Neutral
Rolls-Royce upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Olivier Brochet upgraded Rolls-Royce to Neutral and raised his price target for the shares to 930p from 780p.
08/10/18
JPMS
08/10/18
DOWNGRADE
JPMS
Underweight
Rolls-Royce downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst David Perry downgraded Rolls-Royce to Underweight and lowered his price target for the shares to GBP 8.40 from GBP 9.65. The analyst believes the company's earnings quality is deteriorating.

TODAY'S FREE FLY STORIES

LRCX

Lam Research

$195.40

0.56 (0.29%)

07:56
04/25/19
04/25
07:56
04/25/19
07:56
Recommendations
Lam Research analyst commentary at Citi »

Citi ups target on top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TSLA

Tesla

$258.70

-5.15 (-1.95%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Recommendations
Microsoft analyst commentary at BMO Capital »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

VBIV

VBI Vaccines

$2.00

(0.00%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 23

    May

UBSI

United Bankshares

$38.81

0.03 (0.08%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Earnings
United Bankshares reports Q1 EPS 62c, consensus 61c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 15

    May

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Hot Stocks
Huntington Bancshares reaffirms three-year target of 4%-6% revenue growth »

For 2019, sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:52
04/25/19
04/25
07:52
04/25/19
07:52
Downgrade
Anadarko, Occidental Petroleum, Chevron rating change at Jefferies »

Jefferies downgrades…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

MTSI

Macom

$15.86

-0.33 (-2.04%)

07:51
04/25/19
04/25
07:51
04/25/19
07:51
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:49
04/25/19
04/25
07:49
04/25/19
07:49
Hot Stocks
AbbVie reports Q1 global hematologic oncology portfolio revenue $1.173B »

Global net revenues from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Recommendations
Anadarko, Occidental Petroleum, Chevron analyst commentary at Morgan Stanley »

Strategic value of…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

PTC

PTC

$101.94

1.12 (1.11%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Downgrade
PTC rating change  »

PTC downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.65

0.38 (2.20%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Upgrade
NextGen Healthcare rating change  »

NextGen Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Hot Stocks
AbbVie CEO says 'we are off to another excellent start' »

"We are off to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:46
04/25/19
04/25
07:46
04/25/19
07:46
Hot Stocks
AbbVie reports Q1 U.S. HUMIRA sales of $3.215B up 7.1% »

IInternationally, HUMIRA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

AZPN

Aspen Technology

$114.55

2.435 (2.17%)

07:45
04/25/19
04/25
07:45
04/25/19
07:45
Upgrade
Aspen Technology rating change  »

Aspen Technology upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

07:45
04/25/19
04/25
07:45
04/25/19
07:45
General news
Treasury Market Outlook: bond markets are mixed »

Treasury Market Outlook:…

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Downgrade
Xilinx rating change at Needham »

Xilinx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CIGI

Colliers International

$69.14

-0.39 (-0.56%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Hot Stocks
Colliers International acquires affiliate in Sweden »

Colliers International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:43
04/25/19
04/25
07:43
04/25/19
07:43
Earnings
AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75 »

FY19 consensus $8.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HAS

Hasbro

$103.18

2.84 (2.83%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Downgrade
Hasbro rating change at Argus »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

, GE

General Electric

$9.32

-0.025 (-0.27%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Wabtec CEO Ray Betler to retire, Rafael Santana to succeed »

Wabtec (WAB) announced…

WAB

Wabtec

$76.57

-0.19 (-0.25%)

GE

General Electric

$9.32

-0.025 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 08

    May

  • 08

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie raises FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Earnings
AbbVie reports Q1 adjusted EPS $2.14, consensus $2.06 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Earnings
Huntington Bancshares sees FY19 revenue up 4%-7%, consensus $4.76B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

REPL

Replimune Group

$15.32

1 (6.98%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Initiation
Replimune Group initiated  »

Replimune Group added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.